← Leaderboards
Bhawna Poonia
University Of Maryland Baltimore
$1,042,019
Attributed
$1,930,538
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $519.5K · FY2014–20$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$1,930,538 · 2
By mechanism
R01$1,777,038 · 1
R03$153,500 · 1
Top collaborators
- Shyamasundaran Kottilil7 shared
Most similar at University Of Maryland Baltimore
Same institution · by research overlap
- Shashwatee Bagchi$954,672
- Hanping Feng$19,880,798
- Mohammad Mohseni Sajadi$9,238,668
- Erin E O'Connor$757,280
- Brian R Gastman$2,294,964
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneBaseResponseVirusDesignMediatingInjection Drug UseInflammatory MarkerInterestHiv InfectionsImpairmentInfectionInjecting Drug UserCd8-Positive T-LymphocytesAdaptive ImmunityCd4 Positive T LymphocytesHigh PrevalenceHepatitis CHigh RiskCd8b1 GeneDisease ProgressionCaringImmunityExhaustion
Grant awards (9)
Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs$365,025
R01 · FY2020 · DA
Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs$154,500
R01 · FY2020 · DA
Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs$365,853
R01 · FY2019 · DA
Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs$76,700
R01 · FY2019 · DA
Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs$371,083
R01 · FY2018 · DA
Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs$76,700
R01 · FY2018 · DA
Immune correlates of long-term success with DAA therapy in HCV/HIV infected people who inject drugs$367,177
R01 · FY2017 · DA
Genetic Polymorphisms in Rhesus Macaque FcRn and Association with IgG Levels$76,750
R03 · FY2015 · AI · contact PI
Genetic Polymorphisms in Rhesus Macaque FcRn and Association with IgG Levels$76,750
R03 · FY2014 · AI · contact PI